A number of other countries besides Canada have access to medicines regimes: countries of the European Union, including the Netherlands, as well as Switzerland, Norway, India, Hong Kong, Korea, Singapore, and the Philippines. They all differ in many ways.
Perhaps it would be most useful if I provided that information to the committee. I could walk you through it, but it's actually quite complex. For example, there are different requirements and different ways of setting out the quantities exported. There are different approaches to product labelling and diversion as well, depending on the country. The types of products that are eligible are different as well. There are different requirements for importers. There are some differences in notification depending on the system they set up. The duration and the enforcement mechanisms are all different in different ways, though they are all meant to be in line with the WTO waiver.